Both in R&D — Physical & Biological Sciences
Incyte Genomics vs Charles River Laboratories International
Over the past year INCY returned +48.8% and CRL returned +100.4%; their daily moves had a correlation of 0.30.
INCY +48.8% CRL +100.4%Growth of $1, one year, split-adjusted
| Metric | INCY | CRL |
|---|---|---|
| Price | $124.82 | $294.59 |
| Market cap | $25.30B | $14.06B |
| Today | +0.75% | +0.60% |
| 1 month | −2.3% | −0.6% |
| 6 months | +38.2% | +85.1% |
| Year to date | +26.4% | +47.7% |
| 1 year | +52.9% | +102.4% |
| Revenue growth (YoY) | +37.7% | −2.7% |
| Gross margin | 93.7% | 36.2% |
| Net margin | 35.0% | −0.1% |
| P/E (TTM) | 15.7× | — |
| Price / sales | 4.3× | 3.5× |
| Net cash | $4.50B | -$2.43B |
| Dividend yield | — | — |
| Volatility (60d) | 30.4% | 39.9% |
| Short % of float | 6.0% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).